PHARMASTRAT CONSULTING APS: Financial statements 2022
CVR: 43346318
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PHARMASTRAT CONSULTING APS (CVR 43346318) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 260,263 and a net result of DKK 25,000. Equity in the 2022 report amounted to DKK 907,128. The solvency ratio was 62.2%.
- Gross Profit
- DKK 260,263
- Profit/Loss
- DKK 25,000
- Equity
- DKK 907,128
- Total Assets
- DKK 1,457,370
- Employees
- 0
Official annual report
Keep an eye on PHARMASTRAT CONSULTING APS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of June 23, 2022, Nicolas Clément Tipsmark Bouchet is registered as adm. dir. of PHARMASTRAT CONSULTING APS.
As of June 23, 2022, Nicolas Clément Tipsmark Bouchet is registered as an owner of PHARMASTRAT CONSULTING APS with an ownership share of 100%.
PHARMASTRAT CONSULTING APS was founded on June 23, 2022.
About PHARMASTRAT CONSULTING APS
PHARMASTRAT CONSULTING APS is a Danish company of the type Anpartsselskab based in København SV, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Nicolas Clément Tipsmark Bouchet. The company is owned by Nicolas Clément Tipsmark Bouchet. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,120 and a net result of DKK -29,821 compared with DKK -3,991 the year before. Equity in the 2025 report amounted to DKK 2,470,929.